🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This international, multi-center, Phase 2/3 trial will study the safety, to...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-03-02
Trial ID
NCT03019185
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of RTA 402 i...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02316821
This extended access study will assess the long-term safety and tolerabilit...
Status
Terminated
Location
Banner University Medical Center, Phoenix Advanced Lung Disease Institute
Start Date
2017-04-18
Trial ID
NCT03068130
Treatments Being Tested
To investigate changes in body weight and body composition in obese adults ...
Status
Completed
Location
Applied Bio-Pharmatech Kurume Clinical Pharmacology Clinic
Start Date
2019-08-20
Trial ID
NCT04018339
Treatments Being Tested
To determine the effects of three different doses of bardoxolone methyl adm...
Status
Completed
Location
West Houston Clinical Research Services
Start Date
2008-04-30
Trial ID
NCT00664027
Treatments Being Tested
This multi-center, randomized, double-blind, placebo-controlled, Phase 2 tr...
Status
Completed
Location
California Institute of Renal Research
Start Date
2021-02-09
Trial ID
NCT04702997
Treatments Being Tested
This study assesses the safety and efficacy of RTA 402 in combination with ...
Status
Terminated
Location
Rocky Mountain Cancer Center (US Oncology)
Start Date
2007-09-30
Trial ID
NCT00529113
This extended access study will assess the long-term safety and tolerabilit...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2019-03-08
Trial ID
NCT03749447
Treatments Being Tested
This international, multi-center, randomized, double-blind, placebo-control...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2019-05-29
Trial ID
NCT03918447
Treatments Being Tested
Primary: * To determine the dose-limiting toxicity, maximum tolerated dose...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2006-04
Trial ID
NCT00508807
Treatments Being Tested